Username Password
S&P 500: 1,317.82 Change: +0.03%
mdmoney
mdmoney
P&P Score: 98.46
Stats
mdmoney IS BEATING THE MARKET TODAY
Points: 21.37 (+0.05)
Accuracy: 80.00%
Annual Return: 1.01% 
(2.05% since 5/19/10)
Average Pick Score: 19.71
About Me
Real name mdmoney
Favorites
mdmoney has no favorites
Groups
mdmoney has no groups
Highlighted Picks
Most Recent  05/23/10
BUY    AMSC   $3.73
AMERICAN SUPERCONDUCTOR CORPORATION   +0.27%
consistent sales and profits
Most Successful  05/23/10
BUY    SPPI   $11.22
SPECTRUM PHARMACEUTICALS INC.   +145.35%
increased sales and profits
Least Successful  05/23/10
BUY    AMSC   $3.73
AMERICAN SUPERCONDUCTOR CORPORATION   -108.32%
consistent sales and profits
Recent Posts
Most Recent Blog Post
mdmoney has no blog posts
Most Recent Comments

mdmoney has no recent comments

Picks

Open
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
05/23/2010 AMSC Rating: 2 BUY Six Months to a Year $29.05 $3.73
(+0.27%)
- -87.16% +21.16% -108.32 view
05/23/2010 SPPI Rating: 3 BUY Six Months to a Year $4.21 $11.22
(+0.40%)
- +166.51% +21.16% +145.35 view
05/17/2010 CERS Rating: 5 BUY Six Months to a Year $2.97 $3.49
(+0.43%)
- +17.51% +15.91% +1.60 view
05/17/2010 IMGN Rating: 2 BUY Three to Six Months $9.18 $14.33
(+0.07%)
- +56.10% +15.91% +40.19 view
05/15/2010 CRIS Rating: 3 BUY Three to Six Months $3.29 $4.74
(-1.25%)
- +44.07% +16.04% +28.03 view
Closed
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
05/23/2010 MOT Rating: 0 BUY Six Months to a Year $6.84 - $9.11 +33.19% +16.93% +16.33 2011-01-03 00:00:00 view
All
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
05/23/2010 AMSC Rating: 2 BUY Six Months to a Year $29.05 $3.73
(+0.27%)
- -87.16% +21.16% -108.32 view
05/23/2010 SPPI Rating: 3 BUY Six Months to a Year $4.21 $11.22
(+0.40%)
- +166.51% +21.16% +145.35 view
05/23/2010 MOT Rating: 0 BUY Six Months to a Year $6.84 - $9.11 +33.19% +16.93% +16.33 2011-01-03 00:00:00 view
05/17/2010 CERS Rating: 5 BUY Six Months to a Year $2.97 $3.49
(+0.43%)
- +17.51% +15.91% +1.60 view
05/17/2010 IMGN Rating: 2 BUY Three to Six Months $9.18 $14.33
(+0.07%)
- +56.10% +15.91% +40.19 view
05/15/2010 CRIS Rating: 3 BUY Three to Six Months $3.29 $4.74
(-1.25%)
- +44.07% +16.04% +28.03 view
Commentary
BUY: AMERICAN SUPERCONDUCTOR CORPORATION (AMSC) Rating: 2
Start Price: $29.05
Points: -108.32
Created: 05/23/2010
consistent sales and profits

Comments: 0 | Comment

Recs:
 
BUY: SPECTRUM PHARMACEUTICALS INC. (SPPI) Rating: 3
Start Price: $4.21
Points: +145.35
Created: 05/23/2010
increased sales and profits

Comments: 0 | Comment

Recs:
 
BUY: MOTOROLA INC (MOT)
Start Price: $6.84
Points: +16.33
Created: 05/23/2010
consistent sales increases and profits

Comments: 0 | Comment

Recs:
 
BUY: CERUS CORPORATION (CERS) Rating: 5
Start Price: $2.97
Points: +1.60
Created: 05/17/2010
The INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. The Company markets the INTERCEPT system for both platelets and plasma in Europe and the Middle East. Imagine if the FDA approves it in the USA.

Comments: 0 | Comment

Recs:
 
BUY: IMMUNOGEN INC. (IMGN) Rating: 2
Start Price: $9.18
Points: +40.19
Created: 05/17/2010
Targeted Antibody Payload (TAP), technology consists of a monoclonal antibody that binds specifically to an antigen target found on cancer cells with multiple copies of one of its cell-killing agents attached using one of its linkers.

Comments: 0 | Comment

Recs:
 
BUY: CURIS INC. (CRIS) Rating: 3
Start Price: $3.29
Points: +28.03
Created: 05/15/2010
an orally-administered small molecule Hedgehog pathway inhibitor to stop cancer

Comments: 0 | Comment

Recs:
 
Sponsored Links